Alejandro Gonzalez
MD
Thoracic Medical Oncologist
👥Biography 个人简介
Alejandro Gonzalez-Larriba is a Spanish thoracic medical oncologist who contributed to the NADIM and NADIM II trials of neoadjuvant nivolumab plus chemotherapy in resectable NSCLC. NADIM II showed significant improvements in pathologic complete response and progression-free survival with chemo-IO. His work is part of the Spanish Lung Cancer Group.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Alejandro Gonzalez 的研究动态
Follow Alejandro Gonzalez's research updates
留下邮箱，当我们发布与 Alejandro Gonzalez（Hospital Universitario Doce de Octubre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment